Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS)
CNY 63.3
(-2.62%)
CNY 63.3
(-2.62%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.79 Billion CNY | -23.66% |
| 2022 | 3.66 Billion CNY | 47.56% |
| 2021 | 2.48 Billion CNY | 168.98% |
| 2020 | 923.28 Million CNY | 58.05% |
| 2019 | 584.19 Million CNY | 31.5% |
| 2018 | 444.23 Million CNY | -41.3% |
| 2017 | 756.8 Million CNY | 52.96% |
| 2016 | 494.75 Million CNY | 30.57% |
| 2015 | 378.92 Million CNY | 68.27% |
| 2014 | 225.18 Million CNY | 0.12% |
| 2013 | 224.92 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.55 Billion CNY | -8.79% |
| 2024 Q3 | 2.13 Billion CNY | -2.87% |
| 2024 Q2 | 2.19 Billion CNY | -14.07% |
| 2023 Q1 | 3.47 Billion CNY | -5.14% |
| 2023 Q2 | 3.08 Billion CNY | -11.16% |
| 2023 FY | 2.79 Billion CNY | -23.66% |
| 2023 Q4 | 2.79 Billion CNY | -5.79% |
| 2023 Q3 | 2.96 Billion CNY | -3.84% |
| 2022 Q4 | 3.66 Billion CNY | 5.59% |
| 2022 Q2 | 3.36 Billion CNY | 6.18% |
| 2022 Q1 | 3.17 Billion CNY | 27.65% |
| 2022 FY | 3.66 Billion CNY | 47.56% |
| 2022 Q3 | 3.47 Billion CNY | 3.1% |
| 2021 Q1 | 1.03 Billion CNY | 12.07% |
| 2021 Q4 | 2.48 Billion CNY | 38.07% |
| 2021 FY | 2.48 Billion CNY | 168.98% |
| 2021 Q3 | 1.79 Billion CNY | 49.06% |
| 2021 Q2 | 1.2 Billion CNY | 16.63% |
| 2020 Q4 | 923.28 Million CNY | 13.17% |
| 2020 Q3 | 815.86 Million CNY | 19.52% |
| 2020 Q2 | 682.62 Million CNY | 25.73% |
| 2020 Q1 | 542.94 Million CNY | -7.06% |
| 2020 FY | 923.28 Million CNY | 58.05% |
| 2019 FY | 584.19 Million CNY | 31.5% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q4 | 584.19 Million CNY | 0.0% |
| 2018 Q3 | 444.23 Million CNY | -29.29% |
| 2018 FY | 444.23 Million CNY | -41.3% |
| 2018 Q4 | 444.23 Million CNY | 0.0% |
| 2018 Q2 | 628.28 Million CNY | 0.0% |
| 2018 Q1 | 628.28 Million CNY | 0.0% |
| 2017 FY | 756.8 Million CNY | 52.96% |
| 2016 FY | 494.75 Million CNY | 30.57% |
| 2015 FY | 378.92 Million CNY | 68.27% |
| 2014 FY | 225.18 Million CNY | 0.12% |
| 2013 FY | 224.92 Million CNY | 0.0% |